Cowen (COWN) ROCE % : 1.68% (As of Dec. 2022)

View and export this data going back to 2006. Start your Free Trial

What is Cowen ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Cowen's annualized ROCE % for the quarter that ended in Dec. 2022 was 1.68%.

Cowen ROCE % Historical Data

The historical data trend for Cowen's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cowen ROCE % Chart

Cowen Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

ROCE %

Get a 7-Day Free Trial

-0.28

2.42

6.95

8.30

2.02

Cowen Quarterly Data
	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22
ROCE %	Get a 7-Day Free Trial															6.50	6.16	-0.78	0.81	1.68

Cowen ROCE % Calculation

Cowen's annualized ROCE % for the fiscal year that ended in Dec. 2022 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2022 )		(A: Dec. 2021 )		(A: Dec. 2022 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2022 )		(A: Dec. 2021 )		(A: Dec. 2022 )
	=	94.437	/	( ( (8748.814 - 3873.672)	+	(8828.774 - 4371.617) )	/ 2 )
	=	94.437	/	( (4875.142	+	4457.157)	/ 2 )
	=	94.437	/	4666.1495
	=	2.02 %

Cowen's ROCE % of for the quarter that ended in Dec. 2022 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2022 )		(Q: Sep. 2022 )		(Q: Dec. 2022 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2022 )		(Q: Sep. 2022 )		(Q: Dec. 2022 )
	=	78.928	/	( ( (8873.53 - 3912.829)	+	(8828.774 - 4371.617) )	/ 2 )
	=	78.928	/	( ( 4960.701	+	4457.157 )	/ 2 )
	=	78.928	/	4708.929
	=	1.68 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2022) EBIT data.

Cowen (NAS:COWN) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Cowen ROCE % Related Terms

Thank you for viewing the detailed overview of Cowen's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Cowen (COWN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Capital Markets » Cowen Inc (NAS:COWN) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

599 Lexington Avenue, 20th Floor, New York, NY, USA, 10022

Website

https://www.cowen.com

Cowen provides financial services in two segments: the operating company, which includes Cowen Investment Management, investment banking, the markets division, and the research division; and the asset company, which consists of private investments, real estate investments and other legacy investment strategies. Cowen offers investment management services to institutional investors worldwide. The company offers its investment banking and research services to corporations and institutional investors in the U.S. and Europe. Revenue comes primarily through investment banking and brokerage services.

Executives

Lorence H. Kim	director	C/O SERES HEALTH, INC., 161 FIRST STREET, CAMBRIDGE MA 02472
Brett H Barth	director	COWEN INC., 599 LEXINGTON AVENUE, NEW YORK NY 10022
Stephen Lasota	officer: Chief Financial Officer	599 LEXINGTON AVENUE, NEW YORK NY 10022
John J Holmes	officer: Chief Administrative Officer	COWEN GROUP, INC., 599 LEXINGTON AVENUE, NEW YORK NY 10022
Owen S Littman	officer: General Counsel	COWEN GROUP, INC., 599 LEXINGTON AVENUE, NEW YORK NY 10022
Jeffrey M Solomon	10 percent owner, officer: Chmn Inv Comm/Prod Dev	599 LEXINGTON AVENUE 20TH FLOOR, NEW YORK NY 10022
Gregg A Gonsalves	director	C/O CEDAR REALTY TRUST, INC., 44 SOUTH BAYLES AVENUE, PORT WASHINGTON NY 11050
Lawrence E Leibowitz	director	C/O NYSE EURONEXT, 11 WALL STREET, NEW YORK NY 10005
Margaret L Poster	director	C/O COWEN INC., 599 LEXINGTON AVENUE, NEW YORK NY 10022
Peter A Cohen	director, 10 percent owner, officer: Chairman, CEO, President	40 WEST 57TH STREET, SUITE 2020, NEW YORK NY 10019
Douglas Rediker	director	599 LEXINGON AVENUE, NEW YORK NY 11022
Michael Singer	officer: CEO & President, Ramius LLC	599 LEXINGTON AVENUE, NEW YORK NY 10022
Jerome S Markowitz	director	C/O COUGAR TRADING, 375 PARK AVENUE, NEW YORK NY 10021
Labranche George M L Iv	director, officer: Senior Managing Director	ONE EXCHANGE PLAZA, NEW YORK NY 10006-3008
Labranche & Co Inc	other: See Footnotes (1) and (2)	ONE EXCHANGE PLAZA, NEW YORK NY 10006-3008